secwatch.observer — SEC 8-K summary
======================================

Issuer:     BOSTON SCIENTIFIC CORP (BSX)
CIK:        0000885725
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0000885725-25-000024
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Scientific CFO Dan Brennan to retire; Jon Monson named successor effective June 30, 2025
--------------------------------------------------------------------------------

- Dan Brennan retires as EVP & CFO effective June 29, 2025; will remain senior advisor to October 3, 2025.
- Jon Monson promoted to EVP & CFO effective June 30, 2025; previously SVP, Investor Relations and global controller.
- Monson receives base salary of $700,000, bonus target of 80%, and $1.75M equity award vesting over 4 years.
- Monson has been with Boston Scientific for 25+ years; played key roles in finance during pandemic and strategic investments.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885725/000088572525000024/0000885725-25-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885725/000088572525000024/bsx-20250418.htm
  HTML page:      https://secwatch.observer/filing/0000885725-25-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer